Finance
Markets
No recent trading data. The last price we hold for STE is from Jun 3 (48 days ago). This symbol may be delisted, renamed, or halted — the figures below reflect its last active session, not the current market.

STE

stock Healthcare Medical Devices
Steris
$210.19 +0.43 (+0.20%) Delayed · quoted 47d ago
Mixed 52% Steady

What the indicators say

Bearish 0 of 5 trend signals bullish
Momentum · RSI 14 Leaning bearish
43
0oversold 30overbought 70100

RSI 43 — soft momentum, not yet oversold.

EMA 21 $213.86
Below
Near-term trend is down
SMA 50 $217.51
Below
Medium-term trend is down
SMA 200 $241.05
Below
Long-term trend is down
50 / 200-day
Death cross
50-day below the 200-day — bearish
Supertrend $224.27
Downtrend
Price is below the Supertrend band — bearish

A mechanical reading of the chart’s indicators — not investment advice.

Key statsas of Jun 3

The day open and close within the day's range
Low $209.34 High $212.46
Open
$210.19
+0.20%
Close
$210.19
+0.20%
52-week range where the price sits across its year
52w low $195.14 52w high $269.44
Current
$210.19
Prev close
$209.76
Volume 0.54× the 3-month average
0 avg 2× avg
Today
425.08K
3-mo avg
784.38K

Earningscalendar synced from Yahoo 57d ago

Most recent
May 1171 days ago
Next expected
Aug 5in 15 days

Recent earnings dates

  • May 11 71 days ago
  • Feb 4 167 days ago
  • Nov 5, 2025 258 days ago
  • Aug 6, 2025 349 days ago

Past earnings dates come from STE’s 8-K item 2.02 filings; the next date is Yahoo’s when available, otherwise estimated from the recent reporting cadence.

Fundamentalssynced from SEC 51d ago

Strong

Across the nine graded ratios (FY2026 balance-sheet figures, P/E on TTM through Mar 2026 earnings, against the latest price), STE’s fundamentals read as strong overall.

P/E ratio Fair
26.5x

At 26.5x, investors are paying up; a fair amount of future growth is already in the price.

Share price divided by earnings per share: what you pay for each $1 of yearly profit. Roughly 15 to 25 is typical, above 40 is richly priced, and negative means the company is losing money.

Dividend yield Fair
1.17%

A 1.2% yield is modest: a small income on top of whatever the share price does.

The yearly dividend as a percent of the share price: the cash income each share pays out. Around 2 to 6% is healthy; above roughly 8% often signals the payout may be cut.

Profit margin Fair
13.2%

A 13.2% margin is solid, in the ordinary range for a profitable company.

The share of revenue left as profit once every cost is paid. Above 15% is strong; below 5% leaves little cushion against a bad year.

Return on equity Fair
10.9%

A 10.9% return on equity is respectable, in the normal range.

Profit earned on each dollar of shareholder equity: how well the company compounds its owners' capital. Above 15% is strong.

Return on assets Fair
7.3%

A 7.3% return on assets is reasonable for a company of this kind.

Profit earned on each dollar of assets: how efficiently the whole asset base is used. Above 8% is strong.

Debt-to-equity Strong
0.49

At 0.49, the company carries less in liabilities than in equity, a conservative balance sheet.

Total liabilities divided by shareholder equity: how heavily the company leans on borrowing. Below 1 is conservative; above 2 is highly leveraged.

Current ratio Strong
2.09

At 2.09, short-term assets comfortably cover short-term bills.

Current assets divided by current liabilities: whether short-term resources cover short-term bills. Above 1.5 is comfortable; below 1 is tight.

Revenue growth Fair
+8.7%

Revenue grew 8.7% from the prior year: steady, modest expansion.

Change in annual revenue from the prior fiscal year: whether the top line is expanding. Above 10% is strong growth; below 0 means revenue is shrinking.

Earnings growth Strong
+27.3%

Net income grew 27.3% from the prior year: strong profit expansion.

Change in annual net income from the prior fiscal year: whether profit is expanding. Above 10% is strong; below 0 means profit is falling.

Financialssynced from SEC 51d ago

FY2022FY2023FY2024FY2025FY2026
Revenue $4.2B$4.5B$5.1B$5.5B$5.9B
Net income $243.9M$107.0M$378.2M$614.6M$782.3M
Diluted EPS $2.48$1.07$3.81$6.20$7.93
Dividend / share $1.69$1.84$2.03$2.23$2.46
Total assets $11.4B$10.8B$11.1B$10.1B$10.7B
Total liabilities $4.9B$4.7B$4.7B$3.5B$3.5B
Shareholder equity $6.5B$6.1B$6.3B$6.6B$7.2B

Leadershipsynced from SEC 53d ago

  • Carestio Daniel A President and CEO · Director
  • Madsen Julia Sr. VP and GM, Life Sciences
  • Mcgowan Lindsey VP, Chf. Comp. & Quality Offc.
  • Tamaro Renato V.P. & Corporate Treasurer
  • Zangerle John Adam Sr. VP, Gen Counsel, and Sec.
  • Boulud Pierre Director
  • Feldmann Cynthia L Director

Officers and board are drawn from STE’s recent SEC ownership filings (Forms 3, 4 and 5).

Recent leadership changes

Notable recent eventspast year

Large daily moves, new 6-month lows, year-over-year fundamentals swings, and reported leadership changes — pulled from the data this app already holds, never investment advice.

Dividendssynced from Yahoo 52d ago

Pays quarterly Strong
2025 total
$1.77
2026 so far
$0.631 payment
2026 projected
$2.52+42.4% vs 2025

Projection scales STE’s declared payments so far this year up to the inferred cadence, then compares to last year’s total. Between payouts it is an estimate, not a guarantee.

Payment history

  • Feb 17 $0.63
  • Sep 4, 2025 $0.63
  • Jun 10, 2025 $0.57
  • Feb 20, 2025 $0.57
  • Nov 19, 2024 $0.57
  • Sep 5, 2024 $0.57
  • Jun 12, 2024 $0.52
  • Feb 22, 2024 $0.52
  • Nov 20, 2023 $0.52
  • Sep 5, 2023 $0.52
  • Jun 13, 2023 $0.47
  • Feb 23, 2023 $0.47
  • Nov 21, 2022 $0.47
  • Sep 6, 2022 $0.47
  • Jun 13, 2022 $0.43
  • Feb 24, 2022 $0.43
  • Nov 22, 2021 $0.43
  • Sep 2, 2021 $0.43

Recent SEC filingssynced from SEC 51d ago

© 2026 Isaac Bythewood · Some rights reserved